MassMutual Private Wealth & Trust’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390 Sell
114
-104
-48% -$346 ﹤0.01% 2307
2026
Q1
$780 Sell
218
-607
-74% -$2.41K ﹤0.01% 2177
2025
Q4
$2.9K Buy
825
+199
+32% +$681 ﹤0.01% 1886
2025
Q3
$2.04K Buy
626
+184
+42% +$580 ﹤0.01% 1977
2025
Q2
$1.08K Sell
442
-255
-37% -$1.29K ﹤0.01% 2104
2025
Q1
$4.65K Buy
697
+663
+1,950% +$6.55K ﹤0.01% 1637
2024
Q4
$427 Buy
+34
New +$512 ﹤0.01% 2167
2024
Q2
Sell
-25
Closed -$674 2212
2024
Q1
$674 Buy
+25
New +$710 ﹤0.01% 1801

Other funds holding RCKT

MassMutual Private Wealth & Trust's RCKT Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Rocket Pharmaceuticals (RCKT) stake by 48% in Q2 2026, selling an estimated $346 and leaving 114 shares worth $390. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

MassMutual Private Wealth & Trust first reported a position in RCKT in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.65K in Q1 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • MassMutual Private Wealth & Trust held 114 shares of Rocket Pharmaceuticals worth $390 as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 104 Rocket Pharmaceuticals shares in Q2 2026, an estimated $346.
  • Rocket Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2307 holding.
  • MassMutual Private Wealth & Trust first reported a position in Rocket Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • MassMutual Private Wealth & Trust's Rocket Pharmaceuticals position peaked at $4.65K in Q1 2025.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.